Biotech firm Windtree Therapeutics announced plans to acquire up to $700 million in BNB, the fifth-largest cryptocurrency, following the asset's recent all-time high price of $808. The company, trading on Nasdaq as WINT, aims to bolster its balance sheet by raising $520 million through a combination of an equity line of credit and a stock-purchase agreement. Windtree has established a strategic partnership with Kraken for custody and trading services for its BNB purchases. The CEO emphasized the importance of securing additional funds for this initiative. This move aligns with a trend among publicly traded companies to invest in cryptocurrency as a way to enhance their stock prices. Windtree's commitment is part of a broader wave of companies adopting crypto treasury strategies, reflecting a growing acceptance of digital assets in corporate finance.

Source đź”—